Sagittarius Life Science Capital Reinvestment Ratio
Sagittarius Life Science capital reinvestment ratio. Sagittarius Life Science (3205) has a Capital Reinvestment Ratio of 0.66x as of September 2025, meaning it reinvests 1% of its operating cash flow (NT$125.00K) in capital expenditures (NT$83.00K). Check how aggressively does Sagittarius Life Science reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Sagittarius Life Science (2015–2016)
Capital reinvestment ratio of Sagittarius Life Science from 2015 to 2016. This chart tracks Sagittarius Life Science's Capital Reinvestment Ratio across 2 annual periods. Also explore Sagittarius Life Science (3205) net asset momentum to track the company's year-over-year net asset growth rate.
Sagittarius Life Science Capital Reinvestment Ratio by Year (2015–2016)
Sagittarius Life Science capital reinvestment ratio by year from 2015 to 2016. For the full cash flow conversion analysis, see 3205 cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2016 | 0.05x | NT$360.37 Million | NT$19.76 Million | ▲ +342.3% |
| 2015 | 0.01x | NT$237.94 Million | NT$2.95 Million | — |